AlphaQuest’s Sana Biotechnology SANA Stock Holding History

AlphaQuest’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,298	Closed	-$203K	–	1850
2024 Q1	$203K	Buy	+20,298	New	+$152K	0.04%	646

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AlphaQuest's SANA Position: Q2 2024 in Review

AlphaQuest sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 20,298 shares — an estimated $203K sold.

AlphaQuest first reported a position in SANA in Q1 2024 and held it in 1 quarter. The position peaked at $203K in Q1 2024. 148 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

AlphaQuest reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
AlphaQuest sold 20,298 Sana Biotechnology shares in Q2 2024, an estimated $203K.
AlphaQuest first reported a position in Sana Biotechnology in Q1 2024 and held it in 1 quarter.
AlphaQuest's Sana Biotechnology position peaked at $203K in Q1 2024.
148 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on AlphaQuest's 13F filing for Q2 2024, filed 6 Aug 2024.